Literature DB >> 16897120

Lymphocytic interstitial pneumonitis (LIP) in Sjögren's syndrome: a case report and a review of the literature.

Vrishali Dalvi1, Emilio B Gonzalez, Louis Lovett.   

Abstract

Sjõgren's disease is one of the most common rheumatological diseases and can present with a variety of extra-glandular manifestations. Lymphocytic Interstitial Pneumonitis (LIP) is the most common lung pathology in these patients. It is important to know and recognize this condition because it is potentially treatable. It is also frequently misdiagnosed and treated as infectious pneumonia multiple times before the correct diagnosis is made. It is a benign lymphoproliferative disorder characterized histologically by interstitial infiltration with polyclonal lymphocytes and plasma cells. High-resolution CT scan of the lungs shows extensive areas of ground-glass attenuation and interlobular septal thickening with scattered thin-walled cysts. An open-lung biopsy is the best method of diagnosing this condition, as less invasive techniques do not provide an adequate tissue specimen. LIP occurs in a wide variety of settings such as autoimmune disease, HIV disease, and as an adverse reaction to some medications; it is, therefore, considered to be a nonspecific response to many stimuli. The treatment usually consists of corticosteroids and other immunosuppressants, though there have been no controlled trials to date. Establishment of a registry may help better evaluate and treat this disease. We present the case of a patient who was diagnosed with LIP secondary to Sjögren's syndrome and also review the literature available.

Entities:  

Mesh:

Year:  2006        PMID: 16897120     DOI: 10.1007/s10067-006-0351-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

1.  Pulmonary involvement in primary Sjögren's syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients.

Authors:  M Koyama; T Johkoh; O Honda; N Mihara; T Kozuka; N Tomiyama; S Hamada; H Nakamura
Journal:  J Thorac Imaging       Date:  2001-10       Impact factor: 3.000

2.  Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia.

Authors:  A A Liebow; C B Carrington
Journal:  Med Clin North Am       Date:  1973-05       Impact factor: 5.456

3.  Reactive pulmonary lymphoid disorders.

Authors:  A G Nicholson; A C Wotherspoon; T C Diss; D M Hansell; R Du Bois; M N Sheppard; P G Isaacson; B Corrin
Journal:  Histopathology       Date:  1995-05       Impact factor: 5.087

4.  Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment.

Authors:  D Deheinzelin; V L Capelozzi; R A Kairalla; J V Barbas Filho; P H Saldiva; C R de Carvalho
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

5.  Respiratory manifestations in primary Sjögren's syndrome. A clinical, functional, and histologic study.

Authors:  S H Constantopoulos; C S Papadimitriou; H M Moutsopoulos
Journal:  Chest       Date:  1985-08       Impact factor: 9.410

6.  Lymphocytic interstitial pneumonitis. Review of 13 cases.

Authors:  C V Strimlan; E C Rosenow; L H Weiland; L R Brown
Journal:  Ann Intern Med       Date:  1978-05       Impact factor: 25.391

7.  Lymphoid interstitial pneumonia not associated with HIV infection: role of Epstein-Barr virus.

Authors:  V Malamou-Mitsi; M M Tsai; A A Gal; M N Koss; T J O'Leary
Journal:  Mod Pathol       Date:  1992-09       Impact factor: 7.842

8.  Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications.

Authors:  A Pines; N Kaplinsky; D Olchovsky; J Rozenman; O Frankl
Journal:  Chest       Date:  1985-07       Impact factor: 9.410

9.  Lung involvement in Sjögren's syndrome: a comparison between patients with primary and with secondary syndrome.

Authors:  C Vitali; A Tavoni; G Viegi; E Begliomini; A Agnesi; S Bombardieri
Journal:  Ann Rheum Dis       Date:  1985-07       Impact factor: 19.103

Review 10.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  H C Cain; P W Noble; R A Matthay
Journal:  Clin Chest Med       Date:  1998-12       Impact factor: 2.878

View more
  10 in total

1.  Transcription factor MIST1 in terminal differentiation of mouse and human plasma cells.

Authors:  Benjamin J Capoccia; Jochen K M Lennerz; Andrew J Bredemeyer; Jeffery M Klco; John L Frater; Jason C Mills
Journal:  Physiol Genomics       Date:  2010-11-23       Impact factor: 3.107

Review 2.  Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review.

Authors:  Antonella Laria; Alfredo Maria Lurati; Gaetano Zizzo; Eleonora Zaccara; Daniela Mazzocchi; Katia Angela Re; Mariagrazia Marrazza; Paola Faggioli; Antonino Mazzone
Journal:  Front Med (Lausanne)       Date:  2022-05-13

3.  Lymphocytic interstitial pneumonia as a manifestation of SLE and secondary Sjogren's syndrome.

Authors:  Daniel Garcia; Lary Young
Journal:  BMJ Case Rep       Date:  2013-08-02

4.  Imaging manifestations of autoimmune disease-associated lymphoproliferative disorders of the lung.

Authors:  Geewon Lee; Ho Yun Lee; Kyung Soo Lee; Kyung Jong Lee; Hoon-Suk Cha; Joungho Han; Man Pyo Chung
Journal:  Clin Rheumatol       Date:  2013-06-02       Impact factor: 2.980

Review 5.  Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.

Authors:  Rekha Vij; Mary E Strek
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

6.  Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations.

Authors:  Paul J Maglione; Jessica R Overbey; Lin Radigan; Emilia Bagiella; Charlotte Cunningham-Rundles
Journal:  Ann Allergy Asthma Immunol       Date:  2014-05-29       Impact factor: 6.347

7.  Risk factors for primary Sjögren syndrome-associated interstitial lung disease.

Authors:  Yong Wang; Ziliang Hou; Meihua Qiu; Qiao Ye
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

8.  Lymphocytic interstitial pneumonia in primary Sjögren's syndrome: a case report.

Authors:  Ji-Young Kim; Sung-Hoon Park; Seong-Kyu Kim; Dae-Sung Hyun; Yoon Seup Kum; Kyung-Jae Jung; Jung-Yoon Choe
Journal:  Korean J Intern Med       Date:  2011-03-02       Impact factor: 2.884

Review 9.  Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis.

Authors:  Alessia Alunno; Roberto Gerli; Roberto Giacomelli; Francesco Carubbi
Journal:  Biomed Res Int       Date:  2017-11-07       Impact factor: 3.411

10.  Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study.

Authors:  Barkha Amlani; Ghada Elsayed; Umang Barvalia; Jeffrey P Kanne; Keith C Meyer; Nathan Sandbo; Zhanhai Li; Sara S McCoy
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-06-30       Impact factor: 0.670

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.